Key Highlights
- Revolutionizing Patient Care: Integration of FamGenix’s hereditary risk screening with Spesana’s clinical workflow ecosystem.
- Empowering Clinicians: Unprecedented access to actionable data for personalized patient treatment plans.
- Advancing Healthcare Technology: Shared commitment to enhancing patient outcomes through advanced tech and clinical expertise.
Source: Business Wire
Notable Quotes
- “We are excited about the possibilities that this collaboration brings to serve clinicians as they diagnose and treat the patient medicine, which by definition, requires deep understanding of the whole patient.” – Carla Balch, CEO/Founder at Spesana
- “We’re firmly committed to making family health histories a part of every patient’s electronic health record.” – Michael Brammer, CEO/Founder at FamGenix
SoH's Take
This strategic partnership between FamGenix and Spesana is a groundbreaking step in the field of precision medicine. By combining cutting-edge genetic insights with an efficient clinical workflow, this collaboration is poised to significantly enhance patient care. It underscores the growing importance of integrating genetic data and family health histories into standard healthcare practices. This alliance not only signals a shift towards more personalized healthcare but also highlights the potential for technology to profoundly impact patient outcomes. The commitment of both FamGenix and Spesana to this cause is commendable and sets a new standard in the pursuit of advanced healthcare solutions.
